Petros Christopoulos, MD

Department of Medical Oncology, Thoraxklinik and National Center for Tumor Diseases (NCT) at Heidelberg University Medical Center, Heidelberg, Germany

Dr. Christopoulos studied medicine at the University of Athens, Greece, and completed his training in Internal Medicine, Emergency Medicine, Hematology including a subspecialization in allogeneic HSCT, Medical Oncology, Genetic Counseling and Palliative Care at the University Medical Centers of Athens (Greece), Freiburg im Breisgau and Würzburg (both in Germany). As a fellow, he participated in several phase I, II and III clinical trials and applied state-of-the-art methods of cellular and molecular immunology to characterize the cellular immune status of untreated patients with indolent B-cell Non-Hodgkin lymphomas.

Currently, he is dividing his time between the medical oncology service of the Heidelberg University Medical Center and various scientific projects for the Translational Lung Research Center Heidelberg, a member of the German Center for Lung Research (DZL).

He is mainly interested in the systemic immune dysregulation associated with pulmonary neoplasms and thymomas as well as in the molecular risk stratification, monitoring of tumor evolution and strategies for overcoming resistance to tyrosine kinase inhibitors and immunotherapy in lung cancer.